exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
oral breaking #eha2022 crispr #geneediting exa-cel leads to abrogation of #vasoocclusive events in all patients with #sicklecell with pancellular distribution hbf of &gt;50%. contributed to this success offering hope 
Haematologist, red cell disorders and marrow failure. Working towards definitive cure: #BMT #genetherapy. @ImperialNHS @ImperialImmuno @TheEBMT @ApothecariesLDN